-
Lonza Expands Bioconjugation Facility and Third Commercial ADC Approved
contractpharma
July 25, 2019
Expansion of bioconjugation in Visp to meet increasing clinical, launch and commercial market demand.
-
Lonza Selects Rockwell Automation for Digital Pharma Ops
contractpharma
July 18, 2019
Will use PharmaSuite MES software, along with FactoryTalk InnovationSuite to accelerate paperless, 24/7 production of capsules.
-
Lonza Completes $15M Tampa Site Expansion
contractpharma
July 11, 2019
The site now has a new Product Development & QC Lab area with 13 processing suites, two new packaging suites, serialization, and new manufacturing suites.
-
Novartis unloading sterile production facility to Lonza
fiercepharma
July 04, 2019
Novartis, looking to the future, has been shedding some of its manufacturing operations from the past. Some from the recent past.
-
Lonza to Acquire Sterile Fill and Finish Facility from Novartis
contractpharma
July 02, 2019
First facility for Lonza’s Drug Product Services to cover sterile manufacturing for clinical production and commercial launches.
-
Gamida Cell and Lonza to Manufacture Omidubicel
contractpharma
June 20, 2019
Strategic manufacturing agreement is signed for the future commercial production of Phase 3 investigational advanced cell therapy.
-
Lonza to Expand HPAPI Development and Manufacturing Capacity
contractpharma
June 18, 2019
Will develop new facilities at Visp site; enters long term mfg. agreement with AstraZeneca.
-
Lonza Launches Engine Equipment Portfolio
contractpharma
June 12, 2019
New offering aims to address the entire small molecule drug development process.
-
Lonza to Spin Out Specialty Ingredients Segment
contractpharma
June 04, 2019
LSI will operate independently in an effort to grow microbial control business.
-
Lonza Launches Capsugel Zephyr DPI Portfolio
contractpharma
May 20, 2019
Includes a portfolio of high-quality, customizable DPI capsules of different polymers and compositions, and product customization services.